BTEC
EquitiesUSThematicAccumulating
iShares Nasdaq US Biotechnology UCITS ETF
Nasdaq US biotechnology in one product: drug innovation with high volatility.
Key facts
- ISIN
- IE00BYXG2H39
- Provider
- iShares
- Index
- Nasdaq Biotechnology
- TER (annual cost)
- 0.35%
- Replication
- Physical (sampling)
- Distributions
- Accumulating
- Domicile
- Ireland
- Base currency
- USD
- Launch year
- 2017
- Fund size (approx.)
- ~€1bn
Listings
| Exchange | Ticker |
|---|---|
| Xetra | 2B70 |
| London Stock Exchange | BTEC |
| SIX Swiss Exchange | BTEC |
Related articles from the blog
Dollar Cost Averaging (DCA)ETFs
ETF or stocks: Which strategy is right for you?
A guide for investors weighing single stocks against ETFs, covering diversification, cost, taxes and the time each approach really demands.
15 min read
Dollar Cost Averaging (DCA)ETFs
How to build a resilient portfolio
A guide for investors who want to build something stable, simple and rewarding over the long term.
19 min read
Data as of 2026-08. Refreshed periodically. This content is for information only and is not investment advice or a recommendation. Verify the official documents (KID/prospectus) with the provider before any decision.